https://www.thenewswire.com/press-releases/1B2aF8JpJ-gcac-invited-to-join-renowned-cannabis-councils.html Vancouver, British Columbia, Canada – TheNewswire -August 12, 2021 – Global Cannabis Applications Corp. ("GCAC" or the "Company") (CSE:APP) (CNSX:APP.CN)(FSE:2FA) (OTC:FUAPF), a leading medical cannabis chain-of-custody compliance and data platform, announced today that it has accepted an invitation from the Canadian Chamber of Commerce to join the National Cannabis Working Group and the International Cannabis Council.
The National Cannabis Working Group (NCWG), launched in June 2019 consists of Canadian Chamber of Commerce members, including licensed cannabis cultivators, processors, retailers, and industry associations. With seventy (70) members of Canada’s leading leading publicly traded cannabis companies involved in all aspects of the supply chain such as production, processing, and retail, the NCWG advocates for public cannabis policies that foster a strong, competitive economic environment. As part of its membership GCAC will participate in activities such as consultations for Health Canada.
The International Cannabis Council (ICC) is a dedicated entity of the NCWG, which focuses on leveraging the Canadian Chamber’s work and bilateral cooperation with like-minded trade organizations worldwide. The Company’s participation in the council provides it access to the Business at OECD (BIAC) [1]. The OECD (Organization for Economic Co-operation and Development) is an intergovernmental economic organization with 38 member countries.
GCAC’s CEO, Brad Moore, will take seats on both the NCWG and the International Cannabis Council. Moore has long been a proponent for the expanded use of medical cannabis based on a data driven model, as described in the Company’s patent pending Pain to Strain model and encapsulated in its Efixii blockchain software solution. As part of their go-to market strategy in Canada, GCAC recently announced ‘GCAC Funding Cannabis Cultivators That License Efixii’ [2] and ‘GCAC Announces Medical Cannabis Sales License and Shop Update’ [3].
States Moore, “This opportunity will not only showcase the value of using truthful cannabis efficacy data when cannabis companies license our Efixii technology but also act as a resource for regulators and medical professionals across the globe. This invitation is a further endorsement of what GCAC has always held as our core vision-better outcomes for medical cannabis patients.”
Vancouver, British Columbia, Canada – TheNewswire -August 12, 2021 – Global Cannabis Applications Corp. ("GCAC" or the "Company") (CSE:APP) (CNSX:APP.CN)(FSE:2FA) (OTC:FUAPF), a leading medical cannabis chain-of-custody compliance and data platform, announced today that it has accepted an invitation from the Canadian Chamber of Commerce to join the National Cannabis Working Group and the International Cannabis Council.
The National Cannabis Working Group (NCWG), launched in June 2019 consists of Canadian Chamber of Commerce members, including licensed cannabis cultivators, processors, retailers, and industry associations. With seventy (70) members of Canada’s leading leading publicly traded cannabis companies involved in all aspects of the supply chain such as production, processing, and retail, the NCWG advocates for public cannabis policies that foster a strong, competitive economic environment. As part of its membership GCAC will participate in activities such as consultations for Health Canada.
The International Cannabis Council (ICC) is a dedicated entity of the NCWG, which focuses on leveraging the Canadian Chamber’s work and bilateral cooperation with like-minded trade organizations worldwide. The Company’s participation in the council provides it access to the Business at OECD (BIAC) [1]. The OECD (Organization for Economic Co-operation and Development) is an intergovernmental economic organization with 38 member countries.
GCAC’s CEO, Brad Moore, will take seats on both the NCWG and the International Cannabis Council. Moore has long been a proponent for the expanded use of medical cannabis based on a data driven model, as described in the Company’s patent pending Pain to Strain model and encapsulated in its Efixii blockchain software solution. As part of their go-to market strategy in Canada, GCAC recently announced ‘GCAC Funding Cannabis Cultivators That License Efixii’ [2] and ‘GCAC Announces Medical Cannabis Sales License and Shop Update’ [3].
States Moore, “This opportunity will not only showcase the value of using truthful cannabis efficacy data when cannabis companies license our Efixii technology but also act as a resource for regulators and medical professionals across the globe. This invitation is a further endorsement of what GCAC has always held as our core vision-better outcomes for medical cannabis patients.”